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We are happy to bring out this new book entitled ‘Recent trends in Cardiovascular Risks’ 
which is written by scientifically accredited authors across the globe. The primary and sec-
ondary preventions are the effective measures for reducing premature mortality. In context to 
developed countries, there are five existing modifiable risk factors, namely high blood pres-
sure, high cholesterol, tobacco use-smoking, diabetes mellitus and obesity which constitutes 
approximately one-third of all CVD cases [1]. Of which highly preventable risk factors such as 
high blood pressure, obesity and smoking are related to premature mortality and morbidity 
from cardiovascular disease (CVD) [2]. The modifiable risk factors, namely smoking, obe-
sity and lack of physical activity, account to 36%, 20% and 7–12% of coronary artery disease, 
respectively [3].
1. Scenario of Cardiovascular Disease
The incidence of AMI is drastically increasing in major developing countries, and it is noticed 
even in rural population, which has become a potential threat [4]. Other modifiable risk fac-
tors include low socioeconomic status, alcohol use, mental ill-health, psychosocial stress and 
left ventricular hypertrophy. Among the nonmodifiable risk factors are advancing age, hered-
ity or family history, gender, ethnicity or race (Figure 1) [5]. To reduce the global burden of 
mortality from CVD, we need to refine our strategic goals and intervention programs. While 
we find the global population is expected to rise by almost 20% from 6.7 billion to 8.1 billion by 
2030, the crude death rate still remains stable around 8.4 deaths/thousand [1]. Cardiovascular 
diseases were once thought to be the disease of the rich and affluent class of people, but now 
it is more visible among the poor as well. Conventional cardiovascular risk is attributed to 
lifestyle changes and altered metabolic activity.
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2. Changing Trends of Cardiovascular Risks
The most common emerging trends in cardiovascular risk factors include altered lipid profile, 
coronary artery calcium score, lipoprotein (a), apolipoproteins, homocysteine, thrombosis 
markers like fibrinogen, plasminogen activator inhibitor-1, carotid intima-media thickness, 
genotypic variations, nonalcoholic fatty liver disease, C-reactive protein, platelets and birth 
weight levels [6].
These diseases not only affect the well being, but can also dampen the economic growth of 
the country due to enormous healthcare expenditure associated with decreased productivity. 
Even though abundance curative cares are available in urban areas, this alone cannot suffice 
the problem of CVDs. The need of the hour is to focus on its prevention and palliative care 
along with its early diagnosis, and management as it is not the sole responsibility of the health 
care providers alone can tackle this problem.
3. Awareness is a must among mass
There is an urgent need for all of us to change our lifestyle through positive and negative rein-
forcements. In rural areas, we need to adopt start-ups, to create awareness among common 
people so that the disease can be cured at the grassroot level. Through coordination and col-
laboration with health care sectors including the government and pharmaceutical companies, 
the awareness can be generated and the risk can be identified.
4. Contents of the book in brief
In this book, we delineate the various risk factors and the current trends of cardiovascular 
risk factors. This book emphasizes on various issues which are alarming and are potential 
threats for cardiovascular risk. The overall risk assessment of cardiovascular disease using 
multivariate scores in developing countries is one of the approaches. This approach is likely 
Figure 1. Causative pathways for CVD.
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to assure that limited resource in developing countries be allocated to those who need it most. 
The clear justification for cardiovascular risk assessment is crucial for policy decision on the 
 implementation of such a strategy. While many developing countries solely described esti-
mated cardiovascular risk by applying existing CVD risk scores to their population’s cross-
sectional risk factor data, a number of countries have validated and recalibrated existing risk 
scores and only a few have developed a new risk score specific to their populations [7]. To 
enhance the adoption of such a policy in developing countries, an additional strategy by the 
WHO and International Society of Hypertension was developed by deriving both laboratory- 
and nonlaboratory-based CVD risk prediction charts for low- and medium-resource settings in 
countries in different WHO subregions. Significant researches have suggested that a vascular 
segment gives us a clue of atherosclerotic lesions, namely endothelial dysfunctions, macro-
phage activation, cellular proliferation and thrombosis, and they respond differently on medi-
cation [8]. Therapeutic approach of the atherogenic dyslipidemia imposes the correlation with 
proatherogenic individual tendencies in order to correct the further risks [9]. Cardiovascular 
disease appears in coronary arteries when the atherosclerotic lesions evolve from an initial 
accumulation of isolated foam cells in the arterial intima to fatty streaks, followed by the accu-
mulation of cholesterol deposits and atheroma formation [10]. Cardiovascular disease may 
have their origin in the intrauterine life, but also a low birth weight and an extremely rich diet 
increase the risk of obesity and a specific metabolic syndrome in adults [11]. Its incidence and 
mortality is very low in reproductive age women, but it increases with age [12]. Estradiol (E2) 
reduces the development of the early atherosclerotic lesions, in some measure, by its effects on 
the lipid metabolism, with a reduction of the lipid deposits from the intima [13].
5. Facts based on Epidemiological studies
World Health Organization (WHO) conducted numerous studies regarding the mortality 
due to myocardial infarction, stroke and venous thromboembolism in many countries across 
the world. Epidemiological studies revealed an increased incidence of myocardial infarction 
approximately five times higher in individuals between the ages of 40 and 60 years old [14]. 
Hormonal contraceptives, pregnancy and polycystic ovary syndrome in young women and 
menopause in older women are directly linked with cardiovascular diseases [15]. Polycystic 
ovary syndrome should be seen as a metabolic disease, with a high risk in developing diabetes 
mellitus type 2 and different cardiovascular disease, and is less frequent in women in reproduc-
tive age. Another extremely important risk factor involved in women atherosclerosis is heredity. 
Diabetes mellitus induces hypercholesterolemia and in consequence an increase in predisposi-
tion for atherosclerosis in both male and female. The incidence of the myocardial infarction is 
two times higher at patients with diabetes mellitus compared to patients without diabetes.
6. Metabolic Syndrome an emerging threat
In the last few years, the criteria for metabolic syndrome have been reviewed: abdominal 
obesity, increased serum cholesterol, high blood pressure, insulin resistance with or without 
impaired glucose tolerance, pro-inflammatory status, a high level of C-reactive protein and 
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a pro-thrombotic status with a high plasmatic fibrinogen and coagulation factors level [16]. 
Morphological and experimental studies have demonstrated connections between hyper-
lipidemia, especially hypercholesterolemia, and atherosclerosis, in both women and men. 
The  content of the atheroma plaque, which is made of cholesterol and cholesterol esters, the 
structure of the foam cells and the experimental production of atherosclerosis by a high-
fat diet have been initial arguments for the implication of lipids in atherosclerosis genesis. 
Cholesterol and triglycerides are the lipids with the highest impact for atherosclerosis and 
ischemic cardiomyopathy.
HDL-cholesterol has anti-inflammatory, antioxidant and antithrombotic properties that con-
tribute to the improvement of the endothelial function and atherosclerosis inhibition [17]. 
Therefore, as the HDL-cholesterol level is higher, the risk of developing atherosclerosis low-
ers. The physical exercises and moderate consume of ethanol increase the HDL-cholesterol 
level, while the obesity and smoking are decreasing it [18]. High cholesterol diets or saturated 
fats, like the ones from the butter, animal fats and yolk, increase the level of the plasmatic 
cholesterol, while the diets poor in cholesterol and in polyunsaturated fats decrease it.
7. Hypertension as a risk
High blood pressure is a condition characterized by an increase of the systolic value over 140 
mmHg and of the diastolic value over 90 mmHg, being a major risk factor for atherosclerosis 
at all ages, females being less affected. Decreased arterial compliance has a high predictive 
value for cardiovascular events, so its evaluation becomes an important objective in investi-
gating the arterial function.
Recent studies have shown that smoking is the most important adjustable risk factor in 
women and men under 40 years old with acute coronary syndrome, being observed in mostly 
equal parts on those with normal coronary arteries and on those with lesions on one or more 
coronary arteries.
8. Homocystinuria a silent killer
Patients with homocystinuria, which is a congenital metabolic disorder, characterized by ele-
vated levels of circulating homocysteine (>100 μmol/L) and urinary homocysteine, present an 
early vascular injury [19]. Clinical and epidemiological studies revealed a connection between 
the serum levels of homocysteine and peripheral vascular disease, coronary artery disease, 
stroke and venous thrombosis, meaning that a high concentration of homocysteine is associ-
ated with the progression of the atherosclerosis [20].
9. Diabetes and Cardiovascular Disease
Diabetes is now considered as a major and growing health problem worldwide. It causes a 
considerable amount of disability, premature mortality, loss of productivity and increased 
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demands on health care facilities [21]. According to the World Health Organization, 1 in 
20 death is attributable to diabetes, 8700 deaths every day and 6 deaths every minute [22]. 
Cardiovascular disease is the major cause of morbidity and mortality in people with diabetes, 
and coronary heart disease is the most common cause of death among people with type 2 
diabetes. People with diabetes are two to four times more likely to develop CVD compared 
with people without the condition [23].
10. Ferritin as an additional risk
Serum ferritin is the main marker of iron status, and hepcidin is the key regulator of iron 
metabolism, but both are increased in inflammation states; thus, their relationship with patho-
logical processes should be studied with caution. Iron deficiency with severe anemia has been 
also related to oxidative stress as iron is involved in several enzymatic antioxidant systems. 
Most studies deal with the association between iron deposition in tissues and cardiovascular 
risk, while decreased iron status is predominantly related to protection against atherosclero-
sis and coronary heart disease [24].
So concluding the contents of the book, it focuses on the overall emerging risks in develop-
ing and developed countries. We hope that this book would create awareness among mass 
and also in scientific community across the globe. We tried to bring out and cover most of the 
recent trends of cardiovascular risks which is prevalent among the society which we tend to 
condone. It is now high time we look upon ourselves and make resolutions to decrease the 
existing risks factors which we are on. It is never too late to implement than to overlook. We 
wish to get the notes and feedback from our readers and rejoice the success of launching this 
book.
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